We provide you with 20 years of free, institutional-grade data for ARDX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ARDX. Explore the full financial landscape of ARDX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$997,142
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Kelliher Mike | Sale | -5,417 | $5.93 | $32,132 | 2025-08-28 |
| Williams Laura A | Sale | -80,000 | $6.12 | $489,680 | 2025-08-28 |
| Williams Laura A | Derivatives Exercise | 50,000 | 2025-08-28 | ||
| Renz Justin A | Sale | -7,037 | $5.93 | $41,741 | 2025-08-25 |
| Foster Eric Duane | Sale | -15,308 | $5.93 | $90,802 | 2025-08-25 |
| GRAMMER ELIZABETH A | Sale | -5,841 | $5.93 | $34,647 | 2025-08-25 |
| RAAB MICHAEL | Sale | -45,687 | $5.93 | $271,002 | 2025-08-25 |
| Williams Laura A | Sale | -6,261 | $5.93 | $37,138 | 2025-08-25 |
| MOTT DAVID M | Grant, award...etc | 72,714 | 2025-06-23 | ||
| Cadoret-Manier Onaiza | Grant, award...etc | 41,551 | 2025-06-23 | ||
| Bhanji Muna | Grant, award...etc | 41,551 | 2025-06-23 | ||
| Bertrand William C JR | Grant, award...etc | 60,941 | 2025-06-23 | ||
| Bazemore Robert B | Grant, award...etc | 41,551 | 2025-06-23 | ||
| Rodgers Richard J | Grant, award...etc | 63,019 | 2025-06-23 | ||
| Parsey Merdad | Grant, award...etc | 15,235 | 2025-06-23 | ||
| MOTT DAVID M | Open Market Purchase | 200,000 | $3.63 | 2025-06-18 | |
| MOTT DAVID M | Open Market Purchase | 200,000 | $3.69 | 2025-06-11 | |
| GRAMMER ELIZABETH A | Sale | -5,992 | $4.08 | $24,456 | 2025-05-22 |
| Foster Eric Duane | Sale | -2,507 | $4.08 | $10,232 | 2025-05-22 |
| Williams Laura A | Sale | -6,421 | $4.08 | $26,207 | 2025-05-22 |
| Renz Justin A | Sale | -7,218 | $4.08 | $29,460 | 2025-05-22 |
| RAAB MICHAEL | Sale | -46,817 | $4.08 | $191,079 | 2025-05-22 |
| Kelliher Mike | Sale | -14,522 | $4.08 | $59,270 | 2025-05-22 |
| MOTT DAVID M | Open Market Purchase | 100,000 | $3.29 | 2025-05-19 | |
| Parsey Merdad | Grant, award...etc | 42,056 | 2025-05-14 | ||
| RAAB MICHAEL | Sale | -41,666 | $4.25 | $177,168 | 2025-05-05 |
| RAAB MICHAEL | Derivatives Exercise | 20,833 | 2025-05-05 | ||
| MOTT DAVID M | Open Market Purchase | 381,377 | $4.22 | 2025-05-05 | |
| RAAB MICHAEL | Sale | -41,666 | $4.59 | $191,151 | 2025-04-08 |
| RAAB MICHAEL | Derivatives Exercise | 20,833 | 2025-04-08 | ||
| RAAB MICHAEL | Sale | -41,668 | $5.36 | $223,199 | 2025-03-07 |
| RAAB MICHAEL | Derivatives Exercise | 20,834 | 2025-03-07 | ||
| GRAMMER ELIZABETH A | Grant, award...etc | 136,680 | 2025-02-27 | ||
| Foster Eric Duane | Grant, award...etc | 136,680 | 2025-02-27 | ||
| Kelliher Mike | Grant, award...etc | 136,680 | 2025-02-27 | ||
| Renz Justin A | Grant, award...etc | 136,680 | 2025-02-27 | ||
| RAAB MICHAEL | Grant, award...etc | 570,217 | 2025-02-27 | ||
| Williams Laura A | Grant, award...etc | 105,200 | 2025-02-27 | ||
| MOTT DAVID M | Open Market Purchase | 77,729 | $5 | 2025-02-26 | |
| RAAB MICHAEL | Sale | -22,964 | $5.62 | $129,124 | 2025-02-21 |
| Renz Justin A | Sale | -5,171 | $5.62 | $29,077 | 2025-02-21 |
| Williams Laura A | Sale | -4,941 | $5.62 | $27,783 | 2025-02-21 |
| GRAMMER ELIZABETH A | Sale | -4,291 | $5.62 | $24,128 | 2025-02-21 |
| RAAB MICHAEL | Sale | -41,666 | $5.36 | $223,355 | 2025-01-31 |
| RAAB MICHAEL | Derivatives Exercise | 20,833 | 2025-01-31 | ||
| MOTT DAVID M | Open Market Purchase | 199,000 | $4.99 | 2025-01-22 | |
| Rodgers Richard J | Derivatives Exercise | 100,000 | 2025-01-17 | ||
| RAAB MICHAEL | Sale | -41,666 | $5.31 | $221,309 | 2025-01-10 |
| RAAB MICHAEL | Derivatives Exercise | 20,833 | 2025-01-10 | ||
| MOTT DAVID M | Derivatives Exercise | 100,000 | 2024-12-27 | ||
| MOTT DAVID M | Open Market Purchase | 213,300 | $4.67 | 2024-12-23 | |
| RAAB MICHAEL | Sale | -25,000 | $5.26 | $131,620 | 2024-12-12 |
| RAAB MICHAEL | Derivatives Exercise | 25,000 | 2024-12-12 | ||
| RAAB MICHAEL | Sale | -25,000 | $5.38 | $134,483 | 2024-11-27 |
| RAAB MICHAEL | Sale | -31,980 | $4.79 | $153,328 | 2024-11-22 |
| GRAMMER ELIZABETH A | Sale | -7,046 | $4.79 | $33,782 | 2024-11-22 |
| Blanks Robert | Sale | -4,941 | $4.79 | $23,690 | 2024-11-22 |
| Renz Justin A | Sale | -5,260 | $4.79 | $25,219 | 2024-11-22 |
| Williams Laura A | Sale | -7,366 | $4.79 | $35,316 | 2024-11-22 |
| Rosenbaum David P. | Sale | -2,243 | $4.79 | $10,754 | 2024-11-22 |
| Rosenbaum David P. | Sale | -4,941 | $4.79 | $23,690 | 2024-11-22 |
| Reilly Joseph James | Initial | 2024-11-19 | |||
| MOTT DAVID M | Open Market Purchase | 215,868 | $4.62 | 2024-11-14 | |
| RAAB MICHAEL | Sale | -2,743 | $4.9 | $13,441 | 2024-11-12 |
| Rosenbaum David P. | Sale | -27,171 | $6.1 | $165,743 | 2024-11-08 |
| Rosenbaum David P. | Derivatives Exercise | 27,171 | 2024-11-08 | ||
| Rosenbaum David P. | Sale | -27,172 | $5.95 | $161,673 | 2024-11-06 |
| Rosenbaum David P. | Derivatives Exercise | 27,172 | 2024-11-06 | ||
| RAAB MICHAEL | Sale | -25,000 | $5.91 | $147,740 | 2024-10-31 |
| RAAB MICHAEL | Derivatives Exercise | 25,000 | 2024-10-31 | ||
| RAAB MICHAEL | Sale | -7,500 | $6.01 | $45,075 | 2024-10-15 |
| Rosenbaum David P. | Sale | -49,564 | $6.92 | $342,983 | 2024-10-01 |
| RAAB MICHAEL | Sale | -3,000 | $6.07 | $18,210 | 2024-09-27 |
| Rosenbaum David P. | Sale | -5,312 | $6.26 | $33,254 | 2024-09-16 |
| RAAB MICHAEL | Sale | -35,000 | $5.61 | $196,399 | 2024-09-13 |
| RAAB MICHAEL | Derivatives Exercise | 35,000 | 2024-09-13 | ||
| RAAB MICHAEL | Sale | -7,500 | $6.22 | $46,635 | 2024-08-28 |
| Felsch Robert Ora | Sale | -3,567 | $5.86 | $20,904 | 2024-08-22 |
| GRAMMER ELIZABETH A | Sale | -7,089 | $5.86 | $41,544 | 2024-08-22 |
| Blanks Robert | Sale | -4,969 | $5.86 | $29,120 | 2024-08-22 |
| RAAB MICHAEL | Sale | -32,225 | $5.86 | $188,848 | 2024-08-22 |
| Williams Laura A | Sale | -7,412 | $5.86 | $43,437 | 2024-08-22 |
| Rosenbaum David P. | Sale | -2,250 | $5.86 | $13,186 | 2024-08-22 |
| Rosenbaum David P. | Sale | -4,969 | $5.86 | $29,120 | 2024-08-22 |
| Renz Justin A | Sale | -5,289 | $5.86 | $30,995 | 2024-08-22 |
| Rosenbaum David P. | Sale | -20,507 | $6 | $123,042 | 2024-08-20 |
| Rosenbaum David P. | Derivatives Exercise | 20,507 | 2024-08-20 | ||
| Rosenbaum David P. | Sale | -20,000 | $5.94 | $118,740 | 2024-08-20 |
| Foster Eric Duane | Grant, award...etc | 180,000 | 2024-08-16 | ||
| RAAB MICHAEL | Sale | -1,229 | $5.71 | $7,018 | 2024-08-14 |
| RAAB MICHAEL | Sale | -30,000 | $5.64 | $169,314 | 2024-07-31 |
| RAAB MICHAEL | Derivatives Exercise | 30,000 | 2024-07-31 | ||
| RAAB MICHAEL | Sale | -7,500 | $5.97 | $44,768 | 2024-07-17 |
| RAAB MICHAEL | Sale | -2,310 | $6.59 | $15,223 | 2024-06-28 |
| Blanks Robert | Sale | -38,000 | $5.96 | $226,290 | 2024-06-25 |
| MOTT DAVID M | Grant, award...etc | 17,322 | 2024-06-17 | ||
| RAAB MICHAEL | Sale | -35,000 | $6.65 | $232,743 | 2024-06-17 |
| RAAB MICHAEL | Derivatives Exercise | 35,000 | 2024-06-17 | ||
| Bertrand William C JR | Grant, award...etc | 11,023 | 2024-06-17 | ||
| Rodgers Richard J | Grant, award...etc | 12,204 | 2024-06-17 | ||
| Williams Laura A | Sale | -145,000 | $7.12 | $1,032,980 | 2024-06-07 |
| Williams Laura A | Derivatives Exercise | 100,000 | 2024-06-07 | ||
| Rosenbaum David P. | Sale | -17,872 | $7 | $125,104 | 2024-06-05 |
| RAAB MICHAEL | Sale | -7,500 | $6.72 | $50,390 | 2024-05-31 |
| Renz Justin A | Sale | -5,167 | $7.81 | $40,359 | 2024-05-23 |
| RAAB MICHAEL | Sale | -31,484 | $7.81 | $245,922 | 2024-05-23 |
| Felsch Robert Ora | Sale | -3,485 | $7.81 | $27,221 | 2024-05-23 |
| Blanks Robert | Sale | -4,855 | $7.81 | $37,922 | 2024-05-23 |
| GRAMMER ELIZABETH A | Sale | -6,927 | $7.81 | $54,107 | 2024-05-23 |
| Williams Laura A | Sale | -4,794 | $7.81 | $37,446 | 2024-05-23 |
| Rodriguez Susan | Sale | -6,703 | $7.81 | $52,357 | 2024-05-23 |
| Rosenbaum David P. | Sale | -2,198 | $7.81 | $17,169 | 2024-05-23 |
| Rosenbaum David P. | Sale | -4,855 | $7.81 | $37,922 | 2024-05-23 |
| RAAB MICHAEL | Sale | -3,000 | $7.99 | $23,970 | 2024-05-15 |
| Felsch Robert Ora | Sale | -207,988 | $8.81 | $1,831,938 | 2024-05-09 |
| Felsch Robert Ora | Derivatives Exercise | 119,101 | 2024-05-09 | ||
| GRAMMER ELIZABETH A | Sale | -284,170 | $8.87 | $2,520,986 | 2024-05-09 |
| GRAMMER ELIZABETH A | Derivatives Exercise | 219,937 | 2024-05-09 | ||
| Williams Laura A | Sale | -39,949 | $8.35 | $333,574 | 2024-05-07 |
| Williams Laura A | Derivatives Exercise | 30,000 | 2024-05-07 | ||
| GRAMMER ELIZABETH A | Sale | -45,000 | $9 | $405,000 | 2024-05-07 |
| RAAB MICHAEL | Sale | -30,000 | $6.4 | $192,057 | 2024-05-01 |
| RAAB MICHAEL | Derivatives Exercise | 30,000 | 2024-05-01 | ||
| RAAB MICHAEL | Sale | -7,500 | $7.06 | $52,924 | 2024-04-17 |
| RAAB MICHAEL | Sale | -1,518 | $7.31 | $11,097 | 2024-04-02 |
| Kelliher Mike | Grant, award...etc | 160,000 | 2024-03-27 | ||
| GRAMMER ELIZABETH A | Sale | -86,000 | $7.73 | $664,978 | 2024-03-22 |
| Rosenbaum David P. | Sale | -5,183 | $9.2 | $47,684 | 2024-02-28 |
| RAAB MICHAEL | Sale | -22,917 | $8.75 | $200,439 | 2024-02-22 |
| Blanks Robert | Sale | -5,017 | $8.75 | $43,880 | 2024-02-22 |
| GRAMMER ELIZABETH A | Sale | -4,432 | $8.75 | $38,764 | 2024-02-22 |
| Rodriguez Susan | Sale | -6,928 | $8.75 | $60,594 | 2024-02-22 |
| Felsch Robert Ora | Sale | -2,352 | $8.75 | $20,571 | 2024-02-22 |
| Williams Laura A | Sale | -4,803 | $8.75 | $42,008 | 2024-02-22 |
| Renz Justin A | Sale | -5,341 | $8.75 | $46,714 | 2024-02-22 |
| Rosenbaum David P. | Sale | -2,294 | $8.75 | $20,064 | 2024-02-22 |
| Rosenbaum David P. | Sale | -5,017 | $8.75 | $43,880 | 2024-02-22 |
| Rosenbaum David P. | Sale | -15,344 | $9.18 | $140,846 | 2024-02-09 |
The information provided in this report about ARDX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ardelyx, Inc(NASDAQ:ARDX)Â 
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irr...
Website: http://www.ardelyx.com
Founded: 2007
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology